Trials / Conditions / Peritoneal Malignant Mesothelioma
Peritoneal Malignant Mesothelioma
4 registered clinical trials studyying Peritoneal Malignant Mesothelioma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma NCT05001880 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma NCT05449366 | Erasmus Medical Center | Phase 1 / Phase 2 |
| Unknown | Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma NCT05193006 | Hospices Civils de Lyon | — |
| Active Not Recruiting | Pembrolizumab in Treating Patients With Malignant Mesothelioma NCT02399371 | University of Chicago | Phase 2 |